[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ARMR Investing @BretRosenthal on x 2729 followers
Created: 2025-07-21 12:16:00 UTC
$BMY Bristol-Myers supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis accepted for review across four regions globally (47.36 )
XXX engagements
Related Topics investment $bmy stocks healthcare